Skip to main content
. 2019 Nov 1;18(6):6759–6765. doi: 10.3892/ol.2019.11030

Table I.

Association between miR-133a expression and their clinicopathological characteristics in NSCLC patients.

miR-133a YES1


Characteristics Cases High Low P-value Cases High Low P-value
Age (years) 0.256 0.325
  ≥60 30 12 18 31 22 9
  <60 22   5 17 21 16 5
Sex 0.235 0.301
  Male 32   9 23 33 24 9
  Female 20   8 12 19 14 5
Tumor size (mm) 0.082 0.073
  ≤3 35   9 26 36 28 8
  >3 17   8   9 16 10 6
Lymph nodes metastasis 0.048a 0.032a
  Yes 12   5   7 11   5 6
  No 40 12 28 41 33 8
Tumor stage 0.045a 0.033a
  I–II 41 11 30 39 31 8
  III–IV 11   6   5 13   7 6

Statistical analyses were performed by the χ2 test.

a

P<0.05, indicates significant difference. miR-133a, microRNA-133a; NSCLC, non-small cell lung cancer.